Author

A. Alamgir

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

C. A. Alabi· 2 shared S. Ghosal· 2 shared C. Robertus· 1 shared H. W. Chan· 1 shared J. Almonte· 1 shared J. Wang· 1 shared M. DeLisa· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

C. A. Alabi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Bioreversible anionic cloaking enables intracellular protein delivery with ionizable lipid nanoparticles

A. Alamgir, S. Ghosal, M. DeLisa, C. A. Alabi

This study develops a method to deliver proteins into cells using ionizable lipid nanoparticles by modifying protein surfaces with an anionic cloak, demonstrating efficacy in cancer cell killing and signaling inhibition.

ACS Central Science · May 14, 2024Peer-reviewedBioengineering

Nanoparticle-mediated delivery of peptide-based degraders enables targeted protein degradation

S. Ghosal, C. Robertus, J. Wang, H. W. Chan, A. Alamgir, J. Almonte, C. A. Alabi

This study uses lipid nanoparticles to deliver peptide-based degraders, enabling targeted protein degradation in cancer cells and demonstrating reduced target levels in mice.

bioRxiv · Mar 17, 2024 · PreprintBioengineering